DOYLE JANEEN NOEL (Chief Corp. & Bus. Dev. Ofcr) received a stock award from JANUX THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/2/2026ACC: 0002069239-26-000002
Officer· Chief Corp. & Bus. Dev. Ofcr
Since May 2025
+162K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
162K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+36K
Price / share
—
Trade value
—
% of position
81.8%
1/2/2026
44K→80K
Total
Net shares
+36K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +36K | — | — | 81.8% | 44K | 80K |
| Total | +36K | $0.00 | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
126K shares
Shares
+126K
Strike price
13.65
Held after
126K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock126K shares | 1/2/2026 | A · Award | +126K | 13.65 | — | 126K |